BioBank
Association of Ukraine
+38 (050) 400-70-80, +31 (68) 307-53-02

Liver disease​

The Institute of Cell Biorehabilitation uses the latest technologies and achievements of medical researchers from the Saban Research Institute of Los Angeles, USA for the treatment of liver diseases. Scientists have recreated the function of the liver using human stem cells, and also created a model of the liver, consisting of its structural components (hepatocytes, bile ducts, blood vessels). The research results were published in Stem Cells Translational Medicine dated August 30, 2016. Also, our Institute conducts clinical research on the treatment of mesenchymal cells of post-viral liver cirrhosis, the results were presented at the International Congress on Stem Cells and Regenerative Medicine in Miami, USA in 2019.

Ophthalmology

Treatment of vision with stem cells is specialized direction of our Institute. The techniques which we use were developed and first applied in the Moorfields Eye Hospital in London. These revolutionary techniques have restored 85% of the vision in macular degeneration and 65% in diabetic visual impairment. We hope that in the near future this technique will be available to a wide range of patients around the world (Science Alert).

Crohn's disease and nonspecific ulcerative colitis (NUC)

The effectiveness of the use of stem cells for the treatment of Crohn’s disease and NUC, has been confirmed in the work of Japanese scientists from the National Center for Children’s Health and Development. The use of functional stem cells of the intestine, recreated the ability to absorb all food nutrients and the ability to regenerate the intestinal wall.

Diabetes mellitus type I and II

The treatment of patients with type I and type II diabetes is our priority. We use a potentially new approach based on the use of insulin-secretive stem cells together with leading institutions such as the University of Washington School of Medicine and Harvard Medical School. Research data and obtained clinical results of this method are compared with the discovery of antibiotics. Results were published in Nature Communications dated May 10, 2016.

Diseases of the nervous system

At the beginning of all clinical studies of stem cells, was the determination of their ability to regenerate neurons. Researchers at the Munich Ludwig-Maximilians University and the Max Planck Institute for Neuroscience have demonstrated that the use of differentiated stem cells is able to fully restore neural connections. Based on these studies, a drug for the treatment of multiple sclerosis was synthesized. This drug was approved by the FDA, USA. These results are of great importance in the treatment of acquired diseases of the brain and spinal cord.

Exhausted Ovary Syndrome

In our Institute for the treatment of exhausted ovary syndrome, we use the method of Nankai University, China. This technique is based on the use of stem cells isolated from the umbilical cord. According to the results of this therapy, improvements in ovarian function were observed in 87% of patients, and further contributed to the desired pregnancy. It was also noted stabilization of the hormonal state and an increase in the number of antral follicles.

Erectile dysfunction

Our Institute has been engaged in this area for more than 8 years. Our data on the treatment of severe erectile dysfunction are consistent with most of the leading European institutions that were presented at the conference of the European Association of Urology in London. The method we use is especially significant for men with erectile dysfunction as a result of surgical intervention for malignant and benign prostate neoplasms.